Global week ahead: Tech rotation puts European stocks back in play
AstraZenecaAstraZeneca(US:AZN) CNBC·2026-02-08 06:53

Group 1: Market Overview - The Stoxx 600 index in Europe is near record highs, having recorded its 7th positive week in eight, contrasting with the significant declines in U.S. tech stocks [1] - The S&P 500 has dropped nearly 30% from its peak in October 2025, while European stocks appear more resilient [2] Group 2: Corporate Earnings and M&A Activity - UniCredit is a significant player in European M&A, with minority stakes in Commerzbank and Alpha Bank yielding around 20% returns on investment [3] - Commerzbank's CEO indicated that a deal with UniCredit is "not sensible" due to the high valuation of the German bank [4] - L'Oreal is reporting earnings and may pursue acquisitions, having raised 3 billion euros for M&A financing, and recently increased its stake in Galderma [9] Group 3: Healthcare Sector Developments - AstraZeneca is focusing on the Chinese market for weight-loss drugs, while Philips aims to maintain a positive performance with new AI tools [7] - There are concerns following a sell-off in Novo Nordisk shares, which may impact investor sentiment towards AstraZeneca and Philips [7]